- Home
- HROW vs YALA Comparison
HROW vs YALA Comparison
Compare HROW & YALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HROW | YALA |
|---|---|---|
| Founded | 1998 | 2016 |
| Country | United States | United Arab Emirates |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 844.2M |
| IPO Year | 2008 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HROW | YALA |
|---|---|---|
| Price | $28.43 | $5.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $65.00 | $7.28 |
| AVG Volume (30 Days) | ★ 550.4K | 309.7K |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 4.96% |
| EPS Growth | ★ 71.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $28.59 | $0.00 |
| Revenue Next Year | $53.17 | $12.03 |
| P/E Ratio | ★ N/A | $8.76 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.96 | $5.01 |
| 52 Week High | $54.98 | $7.83 |
Technical Indicators
Market Signals| Indicator | HROW | YALA |
|---|---|---|
| Relative Strength Index (RSI) | 36.73 | 55.64 |
| Support Level | $26.96 | $5.22 |
| Resistance Level | $35.87 | $5.66 |
| Average True Range (ATR) | 1.41 | 0.10 |
| MACD | 0.19 | 0.01 |
| Stochastic Oscillator | 36.39 | 74.07 |
Price Performance
Historical ComparisonAbout HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The group has one operating segment, which is the social networking and entertainment platform.